Document Detail


Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
MedLine Citation:
PMID:  22995852     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Low birthweight is a significant risk factor for neonatal and infant death. A prominent cause of low birthweight is infection with Plasmodium falciparum during pregnancy. Antimalarial intermittent preventive therapy in pregnancy (IPTp) and insecticide-treated mosquito nets (ITNs) significantly reduce the risk of low birthweight in regions of stable malaria transmission. We aimed to assess the effectiveness of malaria prevention in pregnancy (IPTp or ITNs) at preventing low birthweight and neonatal mortality under routine programme conditions in malaria endemic countries of Africa.
METHODS: We used a retrospective birth cohort from national cross-sectional datasets in 25 African countries from 2000-10. We used all available datasets from multiple indicator cluster surveys, demographic and health surveys, malaria indicator surveys, and AIDS indicator surveys that were publically available as of 2011. We tried to limit confounding bias through exact matching on potential confounding factors associated with both exposure to malaria prevention (ITNs or IPTp with sulfadoxine-pyrimethamine) in pregnancy and birth outcomes, including local malaria transmission, neonatal tetanus vaccination, maternal age and education, and household wealth. We used a logistic regression model to test for associations between malaria prevention in pregnancy and low birthweight, and a Poisson model for the outcome of neonatal mortality. Both models incorporated the matched strata as a random effect, while accounting for additional potential confounding factors with fixed effect covariates.
FINDINGS: We analysed 32 national cross-sectional datasets. Exposure of women in their first or second pregnancy to full malaria prevention with IPTp or ITNs was significantly associated with decreased risk of neonatal mortality (protective efficacy [PE] 18%, 95% CI 4-30; incidence rate ratio [IRR] 0·820, 95% CI 0·698-0·962), compared with newborn babies of mothers with no protection, after exact matching and controlling for potential confounding factors. Compared with women with no protection, exposure of pregnant women during their first two pregnancies to full malaria prevention in pregnancy through IPTp or ITNs was significantly associated with reduced odds of low birthweight (PE 21%, 14-27; IRR 0·792, 0·732-0·857), as measured by a combination of weight and birth size perceived by the mother, after exact matching and controlling for potential confounding factors.
INTERPRETATION: Malaria prevention in pregnancy is associated with substantial reductions in neonatal mortality and low birthweight under routine malaria control programme conditions. Malaria control programmes should strive to achieve full protection in pregnant women by both IPTp and ITNs to maximise their benefits. Despite an attempt to mitigate bias and potential confounding by matching women on factors thought to be associated with access to malaria prevention in pregnancy and birth outcomes, some level of confounding bias possibly remains.
Authors:
Thomas P Eisele; David A Larsen; Philip A Anglewicz; Joseph Keating; Josh Yukich; Adam Bennett; Paul Hutchinson; Richard W Steketee
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review     Date:  2012-09-18
Journal Detail:
Title:  The Lancet infectious diseases     Volume:  12     ISSN:  1474-4457     ISO Abbreviation:  Lancet Infect Dis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-23     Completed Date:  2013-04-02     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  101130150     Medline TA:  Lancet Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  942-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA. teisele@tulane.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Africa
Animals
Antimalarials / administration & dosage*
Cohort Studies
Drug Combinations
Female
Humans
Infant Mortality
Infant, Low Birth Weight / immunology*
Infant, Newborn
Logistic Models
Malaria, Falciparum / drug therapy,  parasitology,  prevention & control*
Plasmodium falciparum / isolation & purification*
Poisson Distribution
Pregnancy
Pregnancy Complications, Parasitic / drug therapy,  parasitology,  prevention & control*
Pyrimethamine / administration & dosage*
Retrospective Studies
Sulfadoxine / administration & dosage*
Young Adult
Chemical
Reg. No./Substance:
0/Antimalarials; 0/Drug Combinations; 2447-57-6/Sulfadoxine; 37338-39-9/fanasil, pyrimethamine drug combination; 58-14-0/Pyrimethamine
Comments/Corrections
Comment In:
Pathog Glob Health. 2013 Mar;107(2):46   [PMID:  23683328 ]
Lancet Infect Dis. 2012 Dec;12(12):902-3   [PMID:  22995851 ]
Lancet Infect Dis. 2013 Apr;13(4):292-3   [PMID:  23538219 ]
Lancet Infect Dis. 2013 Apr;13(4):292   [PMID:  23538220 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of multi-walled carbon nanotube-polymer nanocomposites by scanning spreading resist...
Next Document:  The characterization and potential impact of melanoma cases with unknown thickness in the United Sta...